Pharmacology

Exenatide vs Insulin Glargine for Body Fat and Cardiac Biomarker Effects

Fed Pract. 2010 November;27(11):42
PDF Download

 

Recommended Reading

Pharmacist's Phone Call Boosts Adherence
Type 2 Diabetes ICYMI
Hypoglycemia Common in Elderly, Even With High HbA1c
Type 2 Diabetes ICYMI
Low Doses Are Key
Type 2 Diabetes ICYMI
Uncertainty Lingers Over Aspirin and Diabetes
Type 2 Diabetes ICYMI
Artificial Pancreas May Help in Meeting Targets
Type 2 Diabetes ICYMI
Pancreatitis Rates Higher in Adults With Diabetes : A U.K. database study of more than 75,000 diabetes patients found a highly significant increase.
Type 2 Diabetes ICYMI
Cystatin C May Be Biomarker for Diabetic Nephropathy
Type 2 Diabetes ICYMI
Ranolazine and HbA1c and FPG
Type 2 Diabetes ICYMI
Effectiveness of Rosiglitazone and Pioglitazone to Reduce Hemoglobin A1c Levels in Veteran Patients With Type 2 Diabetes
Type 2 Diabetes ICYMI
Dual-function Relief in Diabetic Peripheral Neuropathy
Type 2 Diabetes ICYMI